Literature DB >> 23908949

Strengthened tuberculosis control programme and trend of multi-drug resistant tuberculosis rate in Osaka City, Japan.

Akira Shimouchi1, Akihiro Ohkado, Kenji Matsumoto, Jun Komukai, Hideki Yoshida, Nobukatsu Ishikawa.   

Abstract

Osaka City has the highest tuberculosis (TB) notification rates in Japan. In the period 1999-2003, the TB control programme was strengthened, and the Stop TB Strategy was implemented to reduce the number of notified cases. The objective of this study was to assess the effect of these control activities in Osaka City, including the implementation of directly observed treatment (DOT), by analysing TB surveillance and routinely collected data. We reviewed the surveillance data of all sputum smear-positive pulmonary tuberculosis (PTB) cases registered in the Osaka City Public Health Office from 2001 to 2008 and data collected from the routine TB programme. The DOT implementation rate increased from 0% in 2001 to 68% in 2008 for smear-positive PTB cases of the general public and to 61% for all PTB cases of the homeless. The proportion of smear-positive PTB cases that had treatment failure and default combined, declined from 8.0% (52 of 650) in 2001 to 3.6% (20 of 548) in 2006. The proportion of cases among the homeless with previous treatment declined from 28% in 2001 to 15% in 2008. The proportion of cases with multidrug resistant-TB (MDR-TB) among those without previous treatment declined from 1.7% in 2001 to 0.9% in 2008. It is logical that reduction in the failure and default rate would lead to the reduction of cases with previous treatment and TB transmission, including resistant TB, therefore to the reduction of MDR-TB rates.

Entities:  

Mesh:

Year:  2013        PMID: 23908949      PMCID: PMC3729103          DOI: 10.5365/WPSAR.2013.3.4.015

Source DB:  PubMed          Journal:  Western Pac Surveill Response J        ISSN: 2094-7321


  7 in total

1.  [Factors related to the slowdown in the reduction of the tuberculosis incidence rate in Osaka City--structure of the high incidence rate of tuberculosis in Osaka City analyzed by administrative-ward group, five-year period and age group].

Authors:  T Takatorige; Y Aoki; C Tanigake; A Ruful; K Tatara
Journal:  Kekkaku       Date:  2000-09

2.  [DOTS in Japan--Tokyo area].

Authors:  E Toyota
Journal:  Kekkaku       Date:  2001-12

3.  [Tuberculosis annual report 2009 --series 10. Treatment outcome and TB deaths].

Authors: 
Journal:  Kekkaku       Date:  2012-05

4.  Tuberculosis in London: the importance of homelessness, problem drug use and prison.

Authors:  A Story; S Murad; W Roberts; M Verheyen; A C Hayward
Journal:  Thorax       Date:  2007-02-08       Impact factor: 9.139

5.  [Tuberculosis control in Kawasaki City--promoting the DOT program].

Authors:  Yuki Tada; Masako Ohmori; Kunihiko Ito; Michiko Fujiu
Journal:  Kekkaku       Date:  2004-01

6.  [Tuberculosis control in Shinjuku Ward, Tokyo--promoting the DOTS program and its outcome].

Authors:  Sumi Kaguraoka; Masako Ohmori; Yoshiko Takao; Mari Yamada; Masako Muroi; Michiko Nagamine; Keiji Fukazawa; Megumi Nagai; Masako Wada; Hitoshi Hoshino; Takashi Yoshiyama; Hideo Maeda; Nobukatsu Ishikawa
Journal:  Kekkaku       Date:  2008-09

Review 7.  Tuberculosis in the homeless.

Authors:  D M Barclay; J P Richardson; L Fredman
Journal:  Arch Fam Med       Date:  1995-06
  7 in total
  3 in total

1.  Using tuberculosis surveillance data for informed programmatic decision-making.

Authors:  Nobuyuki Nishikiori; Fukushi Morishita
Journal:  Western Pac Surveill Response J       Date:  2013-03-31

2.  Liver hilar tuberculous lymphadenitis successfully diagnosed by laparoscopic lymph node biopsy.

Authors:  Masaki Wakasugi; Masahiro Tanemura; Tsubasa Mikami; Kenta Furukawa; Masahiko Tsujimoto; Hiroki Akamatsu
Journal:  Int J Surg Case Rep       Date:  2015-04-04

3.  Epidemiological features of tuberculosis infection in a rural prefecture of Japan from 2007 to 2018.

Authors:  Yixiao Lu; Guoxi Cai; Yuhang Liu; Fei He; Kiyoshi Aoyagi
Journal:  Sci Rep       Date:  2022-08-05       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.